UPS (NYSE: UPS) has officially wrapped up its acquisition of MNX Global Logistics (MNX), a renowned global provider of time-critical logistics. The acquisition, which received all necessary regulatory approvals, was finalized on November 2, 2023.

This strategic move to bring MNX under the UPS umbrella aims to bolster the company’s capabilities in time-critical logistics, with a particular focus on serving healthcare customers across the United States, Europe, and Asia. MNX is highly regarded for its consistent and punctual delivery of critical goods, and it has a well-established reputation for transporting radiopharmaceuticals and temperature-sensitive products. This expertise will play a pivotal role in aiding UPS Healthcare and its clinical trial logistics subsidiary, Marken, in meeting the ever-growing demand for these specialized services within the healthcare sector.

With the added knowledge and proficiency from MNX, UPS is poised to maintain its position as an industry leader in delivering global services to customers who require time-critical and temperature-sensitive logistics solutions. This acquisition underscores UPS’s ongoing commitment to invest in cutting-edge technologies and capabilities, ultimately ensuring that customers receive the most dependable and efficient logistics solutions available.